PlainRecalls
FDA Drug Moderate Class II Terminated

Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland

Reported: February 8, 2023 Initiated: November 9, 2022 #D-0261-2023

Product Description

Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland

Reason for Recall

CGMP deviations

Details

Recalling Firm
DISCOVERY PHARMA LLC
Units Affected
21,892 tubes
Distribution
CA, FL, WA
Location
Oviedo, FL

Frequently Asked Questions

What product was recalled?
Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland. Recalled by DISCOVERY PHARMA LLC. Units affected: 21,892 tubes.
Why was this product recalled?
CGMP deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on February 8, 2023. Severity: Moderate. Recall number: D-0261-2023.